Company research
Singular Genomics Systems, Inc.
CIK 1850906Updated Sep 24, 2026
Filing activity
Latest filing
50 filings on record · SCHEDULE 13G/A, 8-K, SCHEDULE 13D/A, 4, EFFECT, 25-NSE.
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 265,467,000Source | 327,975,000Source | 355,648,000Source | 30,502,000Source |
| Property, Plant and Equipment, NetUSD | 13,692,000Source | 10,784,000Source | 6,072,000Source | 2,368,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 16,233,000Source | 74,266,000Source | 201,049,000Source | 11,688,000Source |
| Inventory, NetUSD | 13,572,000Source | 18,221,000Source | — | — |
| Assets, CurrentUSD | 192,228,000Source | 268,432,000Source | 347,760,000Source | 27,571,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 4,150,000Source | 4,722,000Source | 8,537,000Source | 652,000Source |
| Operating Lease, Right-of-Use AssetUSD | 57,797,000Source | 45,896,000Source | — | — |
| Other Assets, NoncurrentUSD | 1,150,000Source | 1,152,000Source | 1,129,000Source | 81,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 86,461,000Source | 67,654,000Source | 19,475,000Source | 12,873,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 7,000Source | 7,000Source | 7,000Source | 1,000Source |
| Additional Paid in CapitalUSD | 516,439,000Source | 503,926,000Source | 488,200,000Source | 1,552,000Source |
| Retained Earnings (Accumulated Deficit)USD | -337,595,000Source | -242,775,000Source | -151,896,000Source | -53,125,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 155,000Source | -837,000Source | -138,000Source | 17,000Source |
| Stockholders' Equity Attributable to ParentUSD | 179,006,000Source | 260,321,000Source | 336,173,000Source | -51,555,000Source |
| Liabilities and EquityUSD | 265,467,000Source | 327,975,000Source | 355,648,000Source | 30,502,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 18,287,000Source | 14,118,000Source | 6,744,000Source | 3,690,000Source |
| Operating Lease, Liability, CurrentUSD | 7,764,000Source | 6,323,000Source | — | — |
| Accounts Payable, CurrentUSD | 2,587,000Source | 3,099,000Source | 2,348,000Source | 427,000Source |
| Operating Lease, Liability, NoncurrentUSD | 58,623,000Source | 42,456,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 650,000Source | 1,015,000Source | 2,827,000Source | 714,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 6,079,000Source | 4,583,000Source | 4,278,000Source | 1,592,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 173,900,000Source | 244,600,000Source | 339,200,000Source | — |
| Deferred Tax Liabilities, NetUSD | 15,723,000Source | 13,152,000Source | 115,000Source | 123,000Source |
| Long-term Debt, Current MaturitiesUSD | 1,312,000Source | — | 0Source | 926,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 8,901,000Source | 10,065,000Source | 9,904,000Source | 8,469,000Source |
| Short-term InvestmentsUSD | 157,708,000Source | 170,310,000Source | 138,174,000Source | 15,231,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -94,820,000Source | -90,879,000Source | -98,771,000Source | -27,945,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 11,404,000Source | 13,669,000Source | 9,231,000Source | 1,060,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -348,000Source | 913,000Source | — | — |
| Increase (Decrease) in InventoriesUSD | 3,537,000Source | 13,487,000Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | 267,000Source | -1,168,000Source | 1,854,000Source | -148,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -73,647,000Source | -87,094,000Source | -51,701,000Source | -24,873,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 13,807,000Source | -39,566,000Source | -130,861,000Source | 24,005,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 970,000Source | 6,022,000Source | 4,864,000Source | 1,380,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 19,000Source | 450,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 696,000Source | 901,000Source | 372,128,000Source | 7,515,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -59,144,000Source | -125,759,000Source | 189,566,000Source | 6,647,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 16,833,000Source | 75,977,000Source | 201,736,000Source | 12,170,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 941,000Source | 561,000Source | 569,000Source | 461,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 11,404,000Source | 13,669,000Source | 9,231,000Source | 1,060,000Source |
| Amortization of Debt Issuance CostsUSD | 148,000Source | 165,000Source | 279,000Source | 234,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 173,900,000Source | 244,600,000Source | 339,200,000Source | — |
| DepreciationUSD | 3,510,000Source | 2,431,000Source | 1,133,000Source | 639,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 0Source | -60,000Source | -94,000Source | 0Source |
| Gain (Loss) on Termination of LeaseUSD | 0Source | 334,000Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -94,820,000Source | -90,879,000Source | -98,771,000Source | -27,945,000Source |
| Operating ExpensesUSD | 102,243,000Source | 93,463,000Source | 61,279,000Source | 27,534,000Source |
| Other Nonoperating Income (Expense)USD | 7,981,000Source | 2,608,000Source | 405,000Source | 41,000Source |
| Proceeds from Issuance of Common StockUSD | 13,000Source | 171,000Source | 3,577,000Source | 45,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | 10,500,000Source | 7,500,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | 800,000Source | — | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 2,911,000Source | 765,000Source | — | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 54,479,000Source | 47,264,000Source | 28,624,000Source | 6,287,000Source |
| Operating Income (Loss)USD | -102,801,000Source | -93,487,000Source | -61,279,000Source | -27,534,000Source |
| Other Nonoperating Income (Expense)USD | 7,981,000Source | 2,608,000Source | 405,000Source | 41,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -94,820,000Source | -90,879,000Source | -98,771,000Source | -27,945,000Source |
| Earnings Per Share, BasicUSD per share | -1.3Source | -1.28Source | — | — |
| Earnings Per Share, DilutedUSD per share | -1.3Source | -1.28Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 72,796,250Source | 71,148,076Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 72,796,250Source | 71,148,076Source | — | — |
| Additional Financial Items | ||||
| Gross ProfitUSD | -558,000Source | -24,000Source | — | — |
| Interest and Other IncomeUSD | 9,082,000Source | 3,371,000Source | 328,000Source | 464,000Source |
| Interest ExpenseUSD | 1,101,000Source | 763,000Source | 846,000Source | 718,000Source |
| Operating ExpensesUSD | 102,243,000Source | 93,463,000Source | 61,279,000Source | 27,534,000Source |
| Research and Development ExpenseUSD | 47,764,000Source | 46,199,000Source | 32,655,000Source | 21,247,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | 800,000Source | — | — |